This document is a publication of a European patent application (EP4271482A2) for "Binder molecules affinity specificity" filed by Alamar Biosciences, Inc. The application, published on March 11, 2026, describes novel binder molecules designed for high affinity and/or specificity, along with their methods of preparation and use. The International Patent Classification (IPC) includes A61P 35/00 (treatment of cancer) and various C07K classifications related to antibodies and binding proteins.

As this is a patent application publication, it does not impose direct compliance obligations or deadlines on regulated entities. However, it signifies potential future intellectual property protection for Alamar Biosciences, Inc. in the specified European states. Companies operating in the peptide and antibody development space should be aware of this publication as it may impact their freedom to operate or future patent filings in related areas.